Who invested in Latern Pharma?
Latern Pharma's investors include Bios Partners and GPG.
United States · Series A startup
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$3.7Mraised across 1 round since 2017, from 1 source
Latern Pharma's investors include Bios Partners and GPG.
Latern Pharma has raised $3.7M across 1 round since 2017.
Latern Pharma's most recent round was a Series A of $3.7M in May 2017.
Its most recent round, $3.7M in May 2017, is also its largest on record.
Latern Pharma's first round on record, in May 2017, was backed by Bios Partners and GPG.
Latern Pharma's latest named round is a Series A, in May 2017.
Latern Pharma is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.